RheoGene, Inc. And TissueGene Inc. Sign Collaborative Agreement For Bone Regeneration And Repair
10/19/2005 5:13:13 PM
NORRISTOWN, PA -- (MARKET WIRE) -- 04/19/2005 -- RheoGene Inc. and TissueGene Inc. (Gaithersburg, MD) have entered into a collaborative research and licensing agreement to develop regulated cell therapy treatments for bone restoration and repair. The companies will combine TissueGene's patented cell therapy technology and RheoGene's proprietary RheoSwitch Therapeutic System (RTS) to develop non-surgical treatments for non-union bone fractures, non-healing bone wounds and osteoporosis.
comments powered by